It has been shown that CCL2 is overexpressed in breast cancer cell lines characterized as triple-negative [58], and silencing its expression led to inhibition of tumor progression depending on blocking the renewal of cancer stem cells and M2 macrophage polarization [59]. This evidence concerns the gene CCL2 and breast cancer.